Global Biopharmaceutical Market Size, Share, Growth Trends And Research Report 2018-2023 - PowerPoint PPT Presentation

About This Presentation

Global Biopharmaceutical Market Size, Share, Growth Trends And Research Report 2018-2023


Want more information about this market: IMARC Group’s latest report titled “Global Biopharmaceutical Manufacturing Market Report 2018-2023” provides a detailed analysis on the global biopharmaceutical manufacturing market. Biopharmaceuticals represent one of the most elegant and sophisticated achievements of modern science. Request a free report sample: Browse more reports on Healthcare industry: contact Us IMARC Group USA: +1-631-791-1145 Email: – PowerPoint PPT presentation

Number of Views:81


Transcript and Presenter's Notes

Title: Global Biopharmaceutical Market Size, Share, Growth Trends And Research Report 2018-2023

    Global Biopharmaceutical Market Boosted by
Increasing Healthcare Expenditures

Copyright IMARC. All Rights Reserved
About IMARC Group
Report Description
IMARC is a leading advisor on management
strategy and market research worldwide. We
partner with clients in all sectors and regions
to identify their highest-value opportunities,
address their most critical challenges, and
transform their businesses. IMARCs information
products include major market, scientific,
economic and technological developments for
business leaders in pharmaceutical, industrial,
and high technology organizations. Market
forecasts and industry analysis for
biotechnology, advanced materials,
pharmaceuticals, food and beverage, travel and
tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
Report Description and Highlights
Report Description
Global Biopharmaceutical Market Boosted by
Increasing Healthcare Expenditures The global
biopharmaceutical market has witnessed a strong
growth over the past few years. Several
beneficial factors of biopharmaceutical drugs
such as their ability to treat various chronic
diseases and reduced side-effects have further
given impetus to the market growth. Biopharmaceu
ticals are large molecule and complex drugs which
are mainly obtained from proteins and nucleic
acids derived from live organisms. They are
usually administered by intravenous, subcutaneous
or intramuscular injections and are more
efficient than the conventional small molecule
drugs. Biopharmaceuticals have changed the
treatment of several diseases, such as diabetes,
cardiovascular diseases, etc., as they can be
tailored for individuals according to their
specific medical requirements. A new research
report by IMARC Group, titled Biopharmaceutical
Market Global Industry Trends, Share, Size,
Growth, Opportunity and Forecast 2018-2023,
estimates that the global biopharmaceutical
market was worth US 185 Billion in 2017,
registering a CAGR of 8 during 2010-2017. The
report further anticipates the market to reach a
value of US 285 Billion by 2023, at a projected
CAGR of 7 during 2018-2023.
Report Description and Highlights
Report Description
  • Global Biopharmaceutical Market
  • Biopharmaceuticals are structurally similar to
    human compounds which increases the potential of
    these drugs to cure diseases rather than merely
    treat the symptoms. This has created a positive
    demand for biopharmaceuticals across the globe.
  • In comparison to conventional drugs,
    biopharmaceuticals have fewer side effects due to
    their specificity. Additionally, these drugs can
    be altered according to the medical requirements
    of the patients which has increased their demand,
    thereby propelling the market growth.
  • Growth in the geriatric population along with a
    rise in the expenditure on healthcare induced by
    inflating per capita incomes is anticipated to
    fuel the biopharmaceuticals market growth.
  • There are several factors that hinder the market
    growth such as high production costs, lack of
    developed cold-chain infrastructure, stringent
    approval laws, impending patent expiries of these
    drugs and supply chain complexity.
  • Read more here https//

Report Description and Highlights
Report Description
Indication Insights On the basis of indication,
autoimmune diseases dominate the market as
biopharmaceuticals are more successful in
treating these diseases as opposed to small
molecule drugs. Autoimmune diseases are followed
by oncology and metabolic disorders.
 Request Sample Of The Report
Report Description and Highlights
Report Description
  • Class Insights
  • Based on class, recombinant proteins account for
    the majority of the total share, representing the
    leading segment. Recombinant proteins are
    followed by monoclonal antibodies and purified
    proteins. Monoclonal antibodies are expected to
    be the fastest growing class on account of high
    unmet medical needs in arthritis, cancer, RSV,
    psoriasis, etc.
  • Regional Insights
  • On a geographical front, the market is mainly
    concentrated in North America and Europe, wherein
    the United States is the largest
    biopharmaceutical market. Other major markets
    include Germany, Japan, France, Italy, Spain, UK
    and Canada.
  • Competitive Landscape
  • The global biopharmaceutical market is
    concentrated in nature with the presence of a
    small number of key players who compete in terms
    of prices and quality. Some of the leading
    players operating in the market are
  • Roche
  • Amgen
  • Novo Nordisk
  • AbbVie
  • Sanofi SA
  • Johnson Johnson

Report Description and Highlights
  • Pfizer
  • Merck Co.
  • Lilly
  • Biogen Idec
  • Browse more related reports 
  • Intravenous Solutions Market https//www.imarcgr
  • Bio preservation Market https//www.imarcgroup.c

Report Description and Highlights
Report Description

2017 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.

Contact Us
Write a Comment
User Comments (0)